Consistently, UA treatment not only led to decreased apoptosis and increased proliferation of transferred CTLs in the tumor, spleen, and lymph node of recipient mice (Figure 1O; Figure S2F,G, Supporting Information) but also dramatically increased the proportion of CTLs with a CD62L+CD44+ TCM phenotype (Figure 1P). This evidence concerns the gene CD44 and neoplasm.